VEGFA and non-small cell lung carcinoma: Additionally, miR-3157-3p is transported from NSCLC cells to vascular endothelial cells through exosomes, targeting the VEGF/MMP2/MMP9 pathway to enhance the formation of new blood vessels (Gu et al., 2021).